Biora Therapeutics

Biora Therapeutics company information, Employees & Contact Information

Updated June 2026

Quick answer

Biora Therapeutics is a Biotechnology Research company. It has approximately 49 employees on record. Contact data was last refreshed in June 2026. Find Biora Therapeutics's verified employee emails, phone numbers, headquarters address, and key decision makers below.

Explore related pages

Biora Therapeutics email format Biora Therapeutics management contacts

Related company profiles:

We create therapeutics platforms designed for needle-free, oral delivery of complex molecules and targeted drug delivery to the GI tract. At Biora, we envision a world where patients have access to needle-free drug delivery and better therapeutic outcomes.

Company Details

Employees
49
Address
10070 Carroll Canyon Road,
Industry
Biotechnology Research
NAICS
Research and Development in Biotechnology (except Nanobiotechnology)
Website
https://bioratherapeutics.com
HQ
San Diego, CA
Competitors
Citius Pharmaceuticals, Inc., Carisma Therapeutics, LENZ Therapeutics, Lineage Cell Therapeutics, Penumbra, Inc., Poseida Therapeutics, Inc., Lantern Pharma Inc. (Nasdaq: LTRN), Milestone Pharmaceuticals, Inc., Halozyme, Inc., Enumera Molecular.
Looking for a particular Biora Therapeutics employee's phone or email?

Biora Therapeutics Questions

News

Biora Therapeutics Successfully Completes Restructuring Process - GlobeNewswire

Biora Therapeutics Successfully Completes Restructuring Process GlobeNewswire

Biora's Fresh Start: Restructuring Success Fuels BioJet Platform Development - Stock Titan

Biora's Fresh Start: Restructuring Success Fuels BioJet Platform Development Stock Titan

Biora Therapeutics Announces Chapter 11 Bankruptcy Filing and Secures $10.25 Million Financing to Support Sale Process and Product Development - Nasdaq

Biora Therapeutics Announces Chapter 11 Bankruptcy Filing and Secures $10.25 Million Financing to Support Sale Process and Product Development Nasdaq

Biora Therapeutics Announces Funding Agreement with Existing Investors - Yahoo Finance

Biora Therapeutics Announces Funding Agreement with Existing Investors Yahoo Finance

Biora Therapeutics Files Chapter 11, Secures $10.25M DIP Financing to Continue BioJet Development - Stock Titan

Biora Therapeutics Files Chapter 11, Secures $10.25M DIP Financing to Continue BioJet Development Stock Titan

Biora Therapeutics Undertakes Chapter 11 Sale Process to Position Business for Future Growth - GlobeNewswire

Biora Therapeutics Undertakes Chapter 11 Sale Process to Position Business for Future Growth GlobeNewswire

Biora Therapeutics has positive oral drug delivery device data for treating ulcerative colitis - Drug Delivery Business

Biora Therapeutics has positive oral drug delivery device data for treating ulcerative colitis Drug Delivery Business

Biora Therapeutics to be delisted from Nasdaq - Investing.com

Biora Therapeutics to be delisted from Nasdaq Investing.com

Biora Therapeutics Provides Corporate Update and Reports Second Quarter 2024 Financial Results - Yahoo Finance

Biora Therapeutics Provides Corporate Update and Reports Second Quarter 2024 Financial Results Yahoo Finance

Biora Therapeutics Announces Positive Clinical Trial Results for BT-600 - Technology Networks

Biora Therapeutics Announces Positive Clinical Trial Results for BT-600 Technology Networks

Biora Therapeutics (BIOR) Stock Price, News & Analysis - MarketBeat

Biora Therapeutics (BIOR) Stock Price, News & Analysis MarketBeat

Biora Therapeutics Provides Corporate Update and Reports Third Quarter 2024 Financial Results - Yahoo Finance

Biora Therapeutics Provides Corporate Update and Reports Third Quarter 2024 Financial Results Yahoo Finance

Biora Therapeutics Reduces Debt and Largest Shareholder Increases Equity Exposure - Yahoo Finance

Biora Therapeutics Reduces Debt and Largest Shareholder Increases Equity Exposure Yahoo Finance

Biora Therapeutics Announces $3 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules - GlobeNewswire

Biora Therapeutics Announces $3 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules GlobeNewswire

Biora Therapeutics Progresses its BioJet™ Systemic Oral Delivery Platform - Yahoo Finance

Biora Therapeutics Progresses its BioJet™ Systemic Oral Delivery Platform Yahoo Finance

Biora Therapeutics Announces Initiation of Phase 1 Clinical Study of BT-600 - GlobeNewswire

Biora Therapeutics Announces Initiation of Phase 1 Clinical Study of BT-600 GlobeNewswire

Biora Therapeutics Announces New Patents for its NaviCap™ Targeted Oral Delivery Platform - Yahoo Finance

Biora Therapeutics Announces New Patents for its NaviCap™ Targeted Oral Delivery Platform Yahoo Finance

Biora Therapeutics Announces Supplemental Data from Phase 1 Clinical Trial of BT-600 as Presented at KOL Event - GlobeNewswire

Biora Therapeutics Announces Supplemental Data from Phase 1 Clinical Trial of BT-600 as Presented at KOL Event GlobeNewswire

Progenity to Become Biora Therapeutics as it Completes Transformation - GlobeNewswire

Progenity to Become Biora Therapeutics as it Completes Transformation GlobeNewswire

Case Summary: Biora Therapeutics Chapter 11 - Bondoro

Case Summary: Biora Therapeutics Chapter 11 Bondoro

Biora Therapeutics News: Latest Updates on the Private BioJet Developer - Meyka

Biora Therapeutics News: Latest Updates on the Private BioJet Developer Meyka

Why Biora Therapeutics Inc. (4ZU0) stock appeals to dividend investors - Long Setup & Weekly Momentum Stock Picks - Trung tâm Dự báo KTTV quốc gia

Why Biora Therapeutics Inc. (4ZU0) stock appeals to dividend investors - Long Setup & Weekly Momentum Stock Picks Trung tâm Dự báo KTTV quốc gia

Biora Therapeutics Gets OK To Take $30M Ch. 11 Asset Bid - Law360

Biora Therapeutics Gets OK To Take $30M Ch. 11 Asset Bid Law360

Biora Therapeutics stock falls as it looks to raise $3M via direct offering - MSN

Biora Therapeutics stock falls as it looks to raise $3M via direct offering MSN

Highbridge Capital Management's Strategic Acquisition of Biora T - GuruFocus

Highbridge Capital Management's Strategic Acquisition of Biora T GuruFocus

BIOR News Today | Why did Biora Therapeutics stock go up today? - MarketBeat

BIOR News Today | Why did Biora Therapeutics stock go up today? MarketBeat

Progenity Completes Exit from Laboratory Business with Sale of Affiliate Lab - GlobeNewswire

Progenity Completes Exit from Laboratory Business with Sale of Affiliate Lab GlobeNewswire

Progenity Announces Pricing of Initial Public Offering - GlobeNewswire

Progenity Announces Pricing of Initial Public Offering GlobeNewswire

Progenity Launches Strategic Transformation into Biotech - GlobeNewswire

Progenity Launches Strategic Transformation into Biotech GlobeNewswire

Companies like Biora Therapeutics

Milestone Pharmaceuticals, Inc. logo - Similar company to Biora Therapeutics

Milestone Pharmaceut...

68
Penumbra, Inc. logo - Similar company to Biora Therapeutics

Penumbra, Inc.

2.84K
Enumera Molecular logo - Similar company to Biora Therapeutics

Enumera Molecular

16
Poseida Therapeutics, Inc. logo - Similar company to Biora Therapeutics

Poseida Therapeutics...

218
LENZ Therapeutics logo - Similar company to Biora Therapeutics

Lenz Therapeutics

144
Carisma Therapeutics logo - Similar company to Biora Therapeutics

Carisma Therapeutics

35
Lantern Pharma Inc. (Nasdaq: LTRN) logo - Similar company to Biora Therapeutics

Lantern Pharma Inc. ...

29
Citius Pharmaceuticals, Inc. logo - Similar company to Biora Therapeutics

Citius Pharmaceutica...

20
Lineage Cell Therapeutics logo - Similar company to Biora Therapeutics

Lineage Cell Therape...

32
Halozyme, Inc. logo - Similar company to Biora Therapeutics

Halozyme, Inc.

463

Top Biora Therapeutics Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant